Stockscreener 앱 받기
34.47
0.23%
-0.15
전일 마감가:
$34.62
열려 있는:
$35.3
하루 거래량:
101.75K
Relative Volume:
0.31
시가총액:
$2.88B
수익:
-
순이익/손실:
-
주가수익비율:
-
EPS:
-
순현금흐름:
-
1주 성능:
-3.41%
1개월 성능:
+5.01%
6개월 성능:
+0.00%
1년 성능:
+0.00%
1일 변동 폭
$33.80
$35.30
1주일 범위
$32.09
$37.29
52주 변동 폭
$28.27
$39.24
Heartflow Inc Stock (HTFL) Company Profile
명칭
Heartflow Inc
전화
650-241-1221
주소
331 E EVELYN AVENUE, MOUNTAIN VIEW
HTFL을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
HTFL
Heartflow Inc
|
34.54 | 2.89B | 0 | 0 | 0 | 0.00 |
|
VEEV
Veeva Systems Inc
|
287.13 | 47.15B | 2.97B | 809.93M | 1.33B | 4.8743 |
|
TEM
Tempus Ai Inc
|
92.24 | 15.61B | 803.32M | -709.10M | -212.68M | -7.8003 |
|
DOCS
Doximity Inc
|
68.20 | 12.55B | 550.17M | 201.35M | 232.07M | 1.00 |
|
HQY
Healthequity Inc
|
92.93 | 8.10B | 1.15B | 96.70M | -161.99M | 1.09 |
|
WAY
Waystar Holding Corp
|
36.55 | 6.99B | 906.14M | -52.62M | 89.62M | -0.3621 |
Heartflow Inc Stock (HTFL) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-09-02 | 개시 | Canaccord Genuity | Buy |
| 2025-09-02 | 개시 | JP Morgan | Overweight |
| 2025-09-02 | 개시 | Morgan Stanley | Equal-Weight |
| 2025-09-02 | 개시 | Piper Sandler | Overweight |
| 2025-09-02 | 개시 | Stifel | Buy |
Heartflow Inc 주식(HTFL)의 최신 뉴스
HTFL Stock Price and Chart — NASDAQ:HTFL - TradingView
Heartflow (NASDAQ:HTFL) Sets New 12-Month HighShould You Buy? - MarketBeat
HTFL Gains FDA Clearance & Cigna Coverage for Next Gen Plaque Analysis - Yahoo Finance
Heartflow, Inc. (NASDAQ:HTFL) Given Average Recommendation of "Moderate Buy" by Brokerages - MarketBeat
Why HeartFlow Stock Rocketed 14% Higher Today - MSN
Heartflow receives FDA clearance for updated plaque analysis platform - MedTech Dive
HTFL Crosses Above Average Analyst Target - Nasdaq
FDA clears Heartflow’s next-gen plaque analysis - BioWorld MedTech
Heartflow (NASDAQ:HTFL) Shares Up 10% Following Analyst Upgrade - MarketBeat
CCORF Maintains Heartflow(HTFL.US) With Buy Rating, Maintains Target Price $39 - 富途牛牛
Heartflow secures FDA clearance for updated plaque analysis platform - Yahoo Finance
Heartflow Announces FDA 510(k) Clearance and Launch of Next Generation Heartflow Plaque Analysis Platform - BioSpace
Heartflow (NASDAQ:HTFL) Given New $39.00 Price Target at Canaccord Genuity Group - Defense World
FDA clears Heartflow’s AI plaque analysis tool, Cigna to cover it - Investing.com
FDA clears Heartflow’s AI plaque analysis tool, Cigna to cover it By Investing.com - Investing.com South Africa
Heartflow stock rises after FDA clearance for Next Gen Plaque Analysis By Investing.com - Investing.com Nigeria
Heartflow stock rises after FDA clearance for Next Gen Plaque Analysis - Investing.com Nigeria
Heartflow announces FDA 510(k) clearance and launch of next generation Heartflow Plaque Analysis platform - MarketScreener
Heartflow Announces FDA 510(K) Clearance And Launch Of Next Generation Heartflow Plaque Analysis Platform - TradingView
Heartflow Receives FDA 510(k) Clearance for Next-Gen Heartflow Plaque Analysis Platform - MarketScreener
Cigna (CI) to Cover Heartflow's Newly Approved Technology - GuruFocus
FDA Clears Heartflow Coronary Plaque Technology - MarketScreener
Heartflow announces FDA clearance of plaque analysis algorithm, Cigna coverage - TipRanks
95% Accuracy vs Gold Standard: HeartFlow's Revolutionary AI Heart Disease Platform Wins FDA Approval - Stock Titan
Heartflow (NASDAQ:HTFL) Stock Price Down 5.2% After Earnings Miss - MarketBeat
Canaccord Genuity raises Heartflow stock price target to $39 on FFRct growth - Investing.com Nigeria
Canaccord Genuity Group Issues Positive Forecast for Heartflow (NASDAQ:HTFL) Stock Price - MarketBeat
Heartflow price target raised to $39 from $35 at Canaccord - TipRanks
Heartflow (NASDAQ:HTFL) Announces Quarterly Earnings Results - MarketBeat
AI-Enabled Heart Diagnostics Put HeartFlow (HTFL) in the Spotlight - MSN
HeartFlow: Q2 Earnings Snapshot - New Haven Register
HeartFlow, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2025 - MarketScreener
Heartflow, Inc. SEC 10-Q Report - TradingView
Stocks Generating Improved Relative Strength: Heartflow - MSN
Heartflow Completes US$364 Million Upsized IPO - Global Legal Chronicle
Heartflow, Inc.'s (NASDAQ:HTFL) Quiet Period Will Expire on September 17th - MarketBeat
HeartFlow, Inc.: Balancing Impressive Growth with Strategic Challenges – A Hold Recommendation - TipRanks
Heartflow (NASDAQ:HTFL) Shares Gap UpHere's Why - MarketBeat
HeartFlow Releases Investor Presentation at Healthcare Conference - TipRanks
Heartflow Incexpects Q2 2025 revenue of $43.4 millionSEC filing - MarketScreener
Heartflow Inc (HTFL) 재무 분석
Heartflow Inc (HTFL)에 대한 금융 데이터가 없습니다. 더 많은 정보를 위해 다른 주식을 확인해보세요.
매출
순이익
현금흐름
주당 순 이익
1.73%
0.59%
자본화:
|
볼륨(24시간):